文章來源：華潤(run)（集(ji)團）有限公司 發布時間：2009-08-26
華潤(run)集(ji)團(tuan)旗下(xia)三九醫(yi)藥股份有(you)限公(gong)(gong)司(si)發布(bu)2008年半年度報告，公(gong)(gong)司(si)實(shi)現營(ying)(ying)業收(shou)入19.10億(yi)元(yuan)(yuan)(yuan)，同(tong)比增長(chang)(chang)19.94％；營(ying)(ying)業利潤(run)2.77億(yi)元(yuan)(yuan)(yuan)，同(tong)比增長(chang)(chang)116.55％；歸(gui)屬(shu)(shu)于母公(gong)(gong)司(si)的(de)凈利潤(run)為2.09億(yi)元(yuan)(yuan)(yuan)，同(tong)比增長(chang)(chang)122.95％；實(shi)現每股收(shou)益0.21元(yuan)(yuan)(yuan)。公(gong)(gong)告還稱，經財務部門初步測算，預計今年前(qian)九個月，實(shi)現的(de)歸(gui)屬(shu)(shu)于母公(gong)(gong)司(si)所有(you)者的(de)凈利潤(run)與上年同(tong)期相比增長(chang)(chang)100%-150%。
今年上半年，三九醫藥股(gu)份公(gong)司醫藥工(gong)業(ye)收(shou)入同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長23.72%，其(qi)中(zhong)(zhong)OTC銷(xiao)(xiao)售(shou)(shou)額(e)(e)同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長14%，中(zhong)(zhong)藥處方(fang)藥銷(xiao)(xiao)售(shou)(shou)額(e)(e)同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長50%，抗生素及(ji)(ji)原(yuan)料藥銷(xiao)(xiao)售(shou)(shou)額(e)(e)同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長66%，延續了較快的增(zeng)(zeng)(zeng)長勢(shi)頭，免煎中(zhong)(zhong)藥銷(xiao)(xiao)售(shou)(shou)額(e)(e)同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長55%。產品方(fang)面，主打產品感(gan)冒靈(ling)銷(xiao)(xiao)售(shou)(shou)同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長26%，達到(dao)2.65億元(yuan)；皮炎平軟膏銷(xiao)(xiao)售(shou)(shou)達到(dao)2.46億元(yuan)，同比(bi)(bi)(bi)增(zeng)(zeng)(zeng)長12.60%，參附及(ji)(ji)生脈銷(xiao)(xiao)售(shou)(shou)分別增(zeng)(zeng)(zeng)長52%及(ji)(ji)230%，三九皮炎平、三九胃泰保持平穩；新(xin)產品小兒感(gan)冒靈(ling)、復(fu)方(fang)氨酚烷胺、無水頭孢唑林鈉等增(zeng)(zeng)(zeng)長快速。